Human
xylosyltransferase is the chain-initiating
enzyme involved in the biosynthesis of
glycosaminoglycans. Large amounts of
xylosyltransferase are required to study the biochemical properties of the native
enzyme. To achieve this goal a scale-up of animal cell culture systems was inevitable due to the small amounts of the
enzyme present in tissues, e.g. only 0.5 microg XT can be obtained from a chick embryo. JAR
choriocarcinoma cells cultured with 10%
fetal calf serum were found to secrete
xylosyltransferase with relatively high activities (1.10 mU l(-1)). To reduce contaminating
proteins JAR cells were adapted to serum-free conditions.
Xylosyltransferase activities up to 0.22 mU l(-1) were determined in the harvested cell culture supernatant. Scaling-up of JAR cell culture in the hybrid hollow fiber
bioreactor Tecnomouse resulted in the production of 15.8 mU or 270 microg XT in 0.5 l of XT-enriched cell culture supernatant using 57 l of serum-free cell culture medium. The XT activity per ml harvest
solution was 200-280-fold higher in this cell culture supernatant than in cell culture flasks. In addition, the specific XT activity of the
bioreactor product was 6 microU mg(-1) of total
protein, which is 2-fold higher than that obtained under static culture conditions. This study clearly demonstrates the successful high-density, tissue-like cultivation of JAR
choriocarcinoma cells in a hollow fiber
bioreactor resulting in an effective production of native human
xylosyltransferase.